Iridex Q1 2024 GAAP EPS $(0.21) Misses $(0.12) Estimate, Sales $11.76M Miss $12.00M Estimate
Portfolio Pulse from Benzinga Newsdesk
Iridex reported Q1 2024 GAAP EPS of $(0.21), missing the $(0.12) estimate, and sales of $11.76M, below the $12.00M estimate. This represents a 61.54% decrease in EPS and a 14.19% decrease in sales from the same period last year.

May 14, 2024 | 8:15 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Iridex's Q1 2024 earnings and sales missed estimates, with a significant decrease compared to last year, indicating potential negative short-term impact on its stock price.
Missing both EPS and sales estimates, especially with such a significant year-over-year decline, typically leads to negative investor sentiment and could result in a short-term decrease in stock price. The magnitude of the miss and the comparison to last year's performance are critical factors influencing this analysis.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100